Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation of the Safety and Efficacy of Pancrecarb® MS-16 in Cystic Fibrosis

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Digestive Care, Inc.
ClinicalTrials.gov Identifier:
NCT00432861
First received: February 7, 2007
Last updated: February 21, 2012
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2007
  Primary Completion Date: September 2007 (Final data collection date for primary outcome measure)